{"id":564361,"date":"2026-08-26T14:00:00","date_gmt":"2026-08-26T12:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/a-diretriz-recomenda-para-alem-dos-anticorpos-anti-ige-tambem-os-anticorpos-anti-il-4%ce%b1-e-a-inibicao-da-btk\/"},"modified":"2026-09-04T09:40:24","modified_gmt":"2026-09-04T07:40:24","slug":"a-diretriz-recomenda-para-alem-dos-anticorpos-anti-ige-tambem-os-anticorpos-anti-il-4%ce%b1-e-a-inibicao-da-btk","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/a-diretriz-recomenda-para-alem-dos-anticorpos-anti-ige-tambem-os-anticorpos-anti-il-4%ce%b1-e-a-inibicao-da-btk\/","title":{"rendered":"A diretriz recomenda, para al\u00e9m dos anticorpos anti-IgE, tamb\u00e9m os anticorpos anti-IL-4\u03b1 e a inibi\u00e7\u00e3o da BTK"},"content":{"rendered":"\n

A nova edi\u00e7\u00e3o das diretrizes internacionais sobre urtic\u00e1ria, publicada em 2026, integra os conhecimentos mais recentes sobre a patog\u00e9nese e as op\u00e7\u00f5es terap\u00eauticas. A urtic\u00e1ria cr\u00f3nica espont\u00e2nea (UCE) abrange diferentes end\u00f3tipos imunol\u00f3gicos com implica\u00e7\u00f5es na escolha do medicamento biol\u00f3gico ou das \u00abpequenas mol\u00e9culas\u00bb adequados. Para al\u00e9m do omalizumab, est\u00e1 dispon\u00edvel na UE o dupilumab, outro anticorpo monoclonal a utilizar como tratamento complementar; al\u00e9m disso, o inibidor oral da BTK, o remibrutinib, obteve entretanto a autoriza\u00e7\u00e3o da EMA \u2013 na Su\u00ed\u00e7a, o remibrutinib foi tamb\u00e9m recentemente autorizado.<\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

A nova edi\u00e7\u00e3o das diretrizes internacionais sobre urtic\u00e1ria, publicada em 2026, integra os conhecimentos mais recentes sobre a patog\u00e9nese e as op\u00e7\u00f5es terap\u00eauticas. A urtic\u00e1ria cr\u00f3nica espont\u00e2nea (UCE) abrange diferentes……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":564362,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Urtic\u00e1ria cr\u00f3nica: tratamento em doentes refrat\u00e1rios aos anti-histam\u00ednicos ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11551,11344,11356,11521,11529],"tags":[100478,100475,82463,28186,62559,13525,100480,100477,100479,13520,15774,100476,84817,100482,100481,72044,18107],"powerkit_post_featured":[],"class_list":["post-564361","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-alergologia-e-imunologia-clinica","category-dermatologia-e-venereologia-pt-pt","category-estudos","category-relatorios-do-congresso","tag-anticorpos-anti-ige","tag-anticorpos-anti-il-4-","tag-barzolvolimab-pt-pt","tag-biologico-pt-pt","tag-csu-pt-pt","tag-dupilumab-pt-pt","tag-embarq-csu","tag-inibicao-da-btk-2","tag-liberty-csu-cupid","tag-omalizumab-pt-pt","tag-pequenas-moleculas","tag-refrataria-aos-anti-histaminicos","tag-remibrutinib-pt-pt","tag-remix","tag-rhapsido","tag-urticaria-cronica","tag-urticaria-espontanea-cronica","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-13 13:47:31","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":564364,"slug":"la-guia-recomienda-ademas-de-los-anticuerpos-anti-ige-los-anticuerpos-anti-il-4%ce%b1-y-la-inhibicion-de-la-btk","post_title":"La gu\u00eda recomienda, adem\u00e1s de los anticuerpos anti-IgE, los anticuerpos anti-IL-4\u03b1 y la inhibici\u00f3n de la BTK","href":"https:\/\/medizinonline.com\/es\/la-guia-recomienda-ademas-de-los-anticuerpos-anti-ige-los-anticuerpos-anti-il-4%ce%b1-y-la-inhibicion-de-la-btk\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/564361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=564361"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/564361\/revisions"}],"predecessor-version":[{"id":564363,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/564361\/revisions\/564363"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/564362"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=564361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=564361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=564361"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=564361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}